CSE RESPIRATORY I COMPLETE REVISION
PACK WITH VENTILATION-PERFUSION,
HYPOXIA, AND AIRWAY SUPPORT CONCEPTS
◉ Stow-severinghaus electrode.
Answer: Used to monitor transcutaneous PCO2
◉ peripherally inserted central catheter (PICC).
Answer: A catheter used for long-term intravenous access
◉ Abdominal thrust.
Answer: Used to assist patients with decreased respiratory muscle
function such as a quadriplegic
◉ Indications of CHF.
Answer: Nocturnal dyspnea, crackles, pulmonary edema ,
hypertension, orthopnea are indications for...
◉ Pulse-dose oxygen device.
Answer: most oxygen is delivered in the 1st quarter of inhalation
with this device
,◉ Non-pressurized aircraft.
Answer: As elevation increases inspired PO2 decreases in this type
of aircraft
◉ Increases.
Answer: Relative humidity of a gas ______ as temperature cools
◉ PAO2.
Answer: FiO2 (Pbarometric - PH2O) - PaCO2/0.8
◉ 85%.
Answer: What percent of surfactant is phospholipid?
◉ Pulmonary embolism.
Answer: Disease process with an excess of ventiation copmared to
perfusion
◉ Lavalbuterol (Xopenex).
Answer: SABA; used to treat asthma and COPD with less side effects
than albuterol
◉ Side effects of nicotine replacment therapy.
,Answer: Side effects include nausea and insomnia
◉ Physiologic deadspace.
Answer: (PaCO2 - PeCO2) / PaCO2
◉ Dornase alfa (Pulmozyme).
Answer: Has been shown to decrease the viscosity of sputum in
cystic fibrosis patients and decrease frequency of exacerbations;
2.5mg/day
◉ Static compliance.
Answer: Vt / (Plateau - PEEP)
◉ Dynamic compliance.
Answer: Vt/ (PIP-PEEP)
◉ Dexmedetomidine (Precedex).
Answer: Indicated for sedation of initially intubated patients; does
not supress respiratory drive; continuous infusion < 24 hours
◉ Supports diagnosis of brain death.
Answer: PaCO2 > 60 mmHg (or 20mmHg rise from baseline)
without respiratory movement
, ◉ Apgar parameters.
Answer: Appearance, Pulse, Grimace, Activity, Respiratory effort
◉ Cisatracurium (Nimbex).
Answer: Paralytic; often given to patients before surgery or during
mechanical ventilation
◉ Succinylcholine.
Answer: Paralytic; rapid onset short life not good for sustaining
paralysis; good for intubation
◉ Tobramycin.
Answer: Inhaled antibiotic standard with cystic fibrosis patients
with lung infections
◉ Peak flow.
Answer: highest flow during forced exhalation
◉ Vital capacity.
Answer: The total volume of air that can be exhaled after maximal
inhalation
PACK WITH VENTILATION-PERFUSION,
HYPOXIA, AND AIRWAY SUPPORT CONCEPTS
◉ Stow-severinghaus electrode.
Answer: Used to monitor transcutaneous PCO2
◉ peripherally inserted central catheter (PICC).
Answer: A catheter used for long-term intravenous access
◉ Abdominal thrust.
Answer: Used to assist patients with decreased respiratory muscle
function such as a quadriplegic
◉ Indications of CHF.
Answer: Nocturnal dyspnea, crackles, pulmonary edema ,
hypertension, orthopnea are indications for...
◉ Pulse-dose oxygen device.
Answer: most oxygen is delivered in the 1st quarter of inhalation
with this device
,◉ Non-pressurized aircraft.
Answer: As elevation increases inspired PO2 decreases in this type
of aircraft
◉ Increases.
Answer: Relative humidity of a gas ______ as temperature cools
◉ PAO2.
Answer: FiO2 (Pbarometric - PH2O) - PaCO2/0.8
◉ 85%.
Answer: What percent of surfactant is phospholipid?
◉ Pulmonary embolism.
Answer: Disease process with an excess of ventiation copmared to
perfusion
◉ Lavalbuterol (Xopenex).
Answer: SABA; used to treat asthma and COPD with less side effects
than albuterol
◉ Side effects of nicotine replacment therapy.
,Answer: Side effects include nausea and insomnia
◉ Physiologic deadspace.
Answer: (PaCO2 - PeCO2) / PaCO2
◉ Dornase alfa (Pulmozyme).
Answer: Has been shown to decrease the viscosity of sputum in
cystic fibrosis patients and decrease frequency of exacerbations;
2.5mg/day
◉ Static compliance.
Answer: Vt / (Plateau - PEEP)
◉ Dynamic compliance.
Answer: Vt/ (PIP-PEEP)
◉ Dexmedetomidine (Precedex).
Answer: Indicated for sedation of initially intubated patients; does
not supress respiratory drive; continuous infusion < 24 hours
◉ Supports diagnosis of brain death.
Answer: PaCO2 > 60 mmHg (or 20mmHg rise from baseline)
without respiratory movement
, ◉ Apgar parameters.
Answer: Appearance, Pulse, Grimace, Activity, Respiratory effort
◉ Cisatracurium (Nimbex).
Answer: Paralytic; often given to patients before surgery or during
mechanical ventilation
◉ Succinylcholine.
Answer: Paralytic; rapid onset short life not good for sustaining
paralysis; good for intubation
◉ Tobramycin.
Answer: Inhaled antibiotic standard with cystic fibrosis patients
with lung infections
◉ Peak flow.
Answer: highest flow during forced exhalation
◉ Vital capacity.
Answer: The total volume of air that can be exhaled after maximal
inhalation
